We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Legal terms for veterinary medicines, marketing of non-medicinal products including medicinal words and phrases, how to complain.
How to get a marketing authorisation for an Advanced Therapy Medicinal Product (ATMP) so it can be sold and/or supplied in Great Britain.
DHSC publications relating to COVID-19 treatments and clinical trials.
Submission dates and how the submissions using the EC decision reliance procedure work.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Current issues relating to imports and exports of animals and animal products.
The T32 exemption allows you to treat non-hazardous pesticide washings in a biobed or biofilter.
How to use an interrupted time series to evaluate your digital health product.
Patients with recurring lymphoma, or who have not responded to prior treatments, could access a new bispecific antibody therapy to help treat their condition.
Actions that trial sponsors should consider to build resilience into clinical trial design
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Information on cleaning an oil spill including your options, how to get a product approved and how long it will take.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Collection of documents relating to COVID-19 treatments.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.